Doctor profile · Federal record
Dr. BABAR RAO, MD
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · Dermatopathology Physician · Dermatology Physician · NEW YORK, NY
- NPI 1447275904
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 43 yrs in practice
- Licensed in 3 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
35 E 35TH ST, STE 208
NEW YORK, NY 100163823
(212) 684-6140
fax (212) 689-5748 - Mailing address
-
66 W GILBERT ST, 2ND FLOOR
TINTON FALLS, NJ 077014947
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- April 9, 2024
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (3)
- New York #211630 · California #A79859 · New Jersey #25MA07004000
- Medicaid
- NJ #8298700
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447275904. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,121
Distinct HCPCS
10
Medicare allowed
$1,668,185
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,344 | 471 | $7 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 1,738 | 941 | $76 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,391 | 919 | $133 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,190 | 727 | $92 | |
17000 |
Destruction of precancer skin growth, 1 growth | 969 | 597 | $58 | |
G6001 |
Ultrasonic guidance for placement of radiation therapy fields | 807 | 48 | $192 | |
77280 |
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 786 | 40 | $288 | |
77401 |
Superficial and/or low voltage radiation treatment delivery | 743 | 40 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 736 | 598 | $101 | |
17110 |
Destruction of skin growth, 1-14 growths | 516 | 343 | $119 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 83× the peer median.Open Payments
Industry payments received
All-time total
$100,721
Transactions
242
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $30,368.26 | |
| Incyte Corporation | 33 | $29,230.33 | |
| Amgen Inc. | 27 | $21,066.03 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $10,595.76 | |
| E.R. Squibb & Sons, L.L.C. | 49 | $6,714.73 | |
| Janssen Biotech, Inc. | 19 | $782.76 | |
| Dermavant Sciences, Inc. | 12 | $342.37 | |
| Novartis Pharmaceuticals Corporation | 21 | $336.99 | |
| GENZYME CORPORATION | 15 | $211.77 | |
| Arcutis Biotherapeutics, Inc. | 13 | $185.44 | |
| Galderma Laboratories, L.P. | 5 | $151.22 | |
| LEO Pharma Inc. | 8 | $133.06 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $125.00 | |
| Verrica Pharmaceuticals Inc. | 5 | $98.58 | |
| UCB, Inc. | 4 | $77.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
953
Patients
697
Total drug cost
$623,227
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 258 | 231 | $2,568 |
| Triamcinolone Acetonide | Generic | 134 | 109 | $1,294 |
| Ketoconazole | Generic | 127 | 91 | $2,712 |
| Clobetasol Propionate | Generic | 59 | 46 | $3,656 |
| Doxycycline Hyclate | Generic | 57 | 47 | $1,435 |
| Cephalexin | Generic | 53 | 50 | $298 |
| Dupixent Pen (Dupilumab) | Brand | 53 | 0 | $199,562 |
| Hydrocortisone | Generic | 52 | 49 | $463 |
| Clindamycin Phosphate | Generic | 40 | 26 | $3,679 |
| Otezla (Apremilast) | Brand | 35 | 0 | $145,307 |